Eugene

[email protected]

LATEST

Roche Extends Offer in $4.3-Billion Spark Acquisition Again
By

By
Roche has again extended its tender offer period relating to its $4.3-billion acquisition of Spark Therapeutics, a Philadelphia-based gene-therapy company, from December 10, 2019 to December 16, 2019. Roche had…

Merck & Co. to Acquire Pharma Company ArQule for $2.7 Billion
By

By
Merck & Co. has agreed to acquire ArQule, a biopharmaceutical company focused on kinase inhibitor discovery and development for cancer and other diseases, for $20 per share in cash for…

Amgen Partners for Outcomes-Based Reimbursement for Blockbuster Enbrel
By

By
Amgen has formed an outcomes-based contract with Abarca, a pharmacy benefit manager (PBM), for Amgen’s blockbuster, Enbrel (etanercept), an anti-inflammatory drug. Under the agreement, Amgen will issue rebates to Abarca’s…

Amgen Selects Location for Research and Development Facility in San Francisco
By

By
Amgen has signed a lease with BioMed Realty for a new 240,000-square-foot Leadership in Energy and Environmental Design (LEED) candidate facility in the Gateway of Pacific Campus in South San…

Bayer Sells Stake in Chemical Park Operator Currenta for $3.9 Billion
By

By
Bayer has completed the sale of its 60% stake in the chemical park operator, Currenta, to funds managed by Macquarie Infrastructure and Real Assets (MIRA). The two companies had entered…

White House Council of Economic Advisors Issues Analysis of House Drug Pricing Plan
By

By
The White House Council of Economic Advisers (CEA) has issued an analysis of the US House of Representatives’ proposed legislation (H.R.3, The Lower Drug Costs Now Act) to address the…

Permira Funds Completes $2.4-Billion Acquisition of Cambrex
By

By
Cambrex, a CMO of small-molecule active pharmaceutical ingredients and drug products, has been acquired by an affiliate of Permira Funds, private-equity firm, for approximately $2.4 billion, including Cambrex’s net debt.…

US Senate Committee Approves FDA Commissioner Nominee
By

By
The US Senate Committee on Health, Education, Labor & Pensions (HELP) has approved the nomination of Dr. Stephen Hahn of MD Anderson Cancer Center to serve as the next Commissioner…

Astellas to Acquire Gene-Therapy Company Audentes for $3 Billion
By

By
Astellas has agreed to acquire Audentes Therapeutics, a San Francisco, California-based adeno-associated virus (AAV)-clinical stage gene-therapy company that focuses on rare neuromuscular diseases, for a total equity value of approximately…

Novartis Opens Cell and Gene Therapy Facility in Switzerland
By

By
Novartis has opened a new cell and gene therapy manufacturing facility at its site in Stein, Switzerland. The site currently houses production for liquid and solid drugs. Cell and gene…